<DOC>
	<DOCNO>NCT00111904</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , paclitaxel , work different way stop growth tumor cell , either kill cell stop dividing . PURPOSE : This phase II trial study well paclitaxel work treat patient unresectable locally advanced metastatic pancreatic cancer .</brief_summary>
	<brief_title>Paclitaxel Treating Patients With Unresectable Locally Advanced Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine time progression time treatment failure patient unresectable locally advanced metastatic epithelial carcinoma pancreas treat paclitaxel load polymeric micelle ( Genexol^®-PM ) . - Determine best overall response rate duration response patient treated drug . - Determine overall survival patient treated drug . - Determine clinical benefit safety drug patient . OUTLINE : Patients receive paclitaxel load polymeric micelle ( Genexol^®-PM ) IV 3 hour day 1 . Courses repeat every 21 day absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 43 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm epithelial carcinoma pancreas Unresectable* locally advance metastatic disease NOTE : *Documented highquality contrastenhanced CT scan No known clinical evidence CNS metastasis PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 01 Life expectancy Not specify Hematopoietic Absolute neutrophil count ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hepatic SGOT SGPT ≤ 2.5 time upper limit normal ( ULN ) Bilirubin ≤ 1.5 time ULN Renal Creatinine ≤ 1.5 time ULN Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No malignancy within past 5 year except curatively treat nonmelanoma skin cancer carcinoma situ No unstable serious medical condition No psychiatric disorder would preclude give informed consent PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy pancreatic cancer Prior fluorouracil radiosensitizer allow Endocrine therapy Not specify Radiotherapy More 6 week since prior radiotherapy pancreatic cancer Disease must progress completion radiotherapy Surgery More 14 day since prior major surgery recover Other More 30 day since prior investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>